New therapy for rare metabolic disorder Pompe disease approved by US FDA

被引：0
|
作者：
不详
机构：
来源：
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM | 2010年 / 5卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：479 / 479
页数：1
相关论文
共 50 条
  • [31] New therapy for metabolic bone disease
    不详
    ORTHOPADE, 2006, 35 (02): : 223 - 224
  • [32] Analysis of the Risks and Benefits of New Chemical Entities Approved by the US Food and Drug Administration (FDA) and Subsequently Withdrawn From the US Market
    Patriarca, Peter A.
    Van Auken, R. Michael
    Kebschull, Scott A.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2018, 52 (05) : 649 - 655
  • [33] Analysis of the Risks and Benefits of New Chemical Entities Approved by the US Food and Drug Administration (FDA) and Subsequently Withdrawn From the US Market
    Peter A. Patriarca
    R. Michael Van Auken
    Scott A. Kebschull
    Therapeutic Innovation & Regulatory Science, 2018, 52 : 649 - 655
  • [34] The 3D pharmacophore modeling to explore new antischistosomal agents among US FDA approved drugs
    Dobrachinski, Leandro
    Ferreira, Leonardo L. G.
    Cirino, Maria E.
    Andrade-de-Siqueira, Allan, I
    Mafud, Ana C.
    Mascarenhas, Yvonne P.
    Andricopulo, Adriano D.
    de Moraes, Josue
    FUTURE MEDICINAL CHEMISTRY, 2024, 16 (17) : 1791 - 1799
  • [35] Medtonic's Consulta((R)) and Syncra (TM) cardiac resynchronization therapy-pacemaker systems approved by the US FDA
    Dowdall, Michael
    FUTURE CARDIOLOGY, 2011, 7 (03) : 290 - 290
  • [36] Clinical insights in enzyme replacement therapy for metabolic storage disorders: lessons from Pompe disease
    van der Beek, Nadine A. M. E.
    Theunissen, Maudy T. M.
    van den Hout, Johanna M. P.
    Pijnappel, Wilhelmus W. M.
    Schoser, Benedikt
    Laforet, Pascal
    Parenti, Giancarlo
    van Doorn, Pieter A.
    van der Ploeg, Ans T.
    LANCET NEUROLOGY, 2025, 24 (03): : 230 - 245
  • [37] Clinical and metabolic correction of Pompe disease by enzyme therapy in acid maltase-deficient quail
    Kikuchi, T
    Yang, HW
    Pennybacker, M
    Ichihara, N
    Mizutani, M
    Van Hove, JLK
    Chen, YT
    JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04): : 827 - 833
  • [38] What's new and what's next for gene therapy in Pompe disease?
    Roger, Angela L.
    Sethi, Ronit
    Huston, Meredith L.
    Scarrow, Evelyn
    Bao-Dai, Joy
    Lai, Elias
    Biswas, Debolina D.
    El Haddad, Lea
    Strickland, Laura M.
    Kishnani, Priya S.
    ElMallah, Mai K.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2022, 22 (09) : 1117 - 1135
  • [39] Metabolic network analysis predicts efficacy of FDA-approved drugs targeting the causative agent of a neglected tropical disease
    Chavali, Arvind K.
    Blazier, Anna S.
    Tlaxca, Jose L.
    Jensen, Paul A.
    Pearson, Richard D.
    Papin, Jason A.
    BMC SYSTEMS BIOLOGY, 2012, 6
  • [40] TRACKING THE SPONSORING COUNTRY OF INCORPORATION FOR NEW DRUGS APPROVED BY THE US FDA IN THE PERIOD 1980-2014: A TREND ANALYSIS
    Alqahtani, S. S.
    Rodriguez-Monguio, R.
    Seoane-Vazquez, E.
    Eguale, T.
    Zeukeng, M. J.
    Szeinbach, S.
    VALUE IN HEALTH, 2015, 18 (03) : A72 - A72
12345